Wholesale of pharmaceutical and medical goods
DNE PHARMA AS
Revenue 2024
NOK 62.3m
Operating profit
NOK 11.3m
Equity
NOK 53.4m
Incorporated
2007
Employees
5
Share capital
NOK 142,000
Varemerker (5)
| Name | Application no. | Reg. no. | Status | Status date | Expires |
|---|---|---|---|---|---|
| Levopidon | 201812211 | 302774 | Registrert | 2019-03-12 | 2028-09-14 |
| Respinal | 201812212 | 302777 | Registrert | 2019-03-12 | 2028-09-14 |
| dne pharma | 201804406 | 300725 | Registrert | 2018-10-19 | 2028-04-03 |
| VentiZolve | 201613000 | 291365 | Registrert | 2017-03-02 | 2026-11-03 |
| DnE | 201308549 | 272846 | Registrert | 2013-10-28 | 2033-07-16 |
Source: Patentstyret
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.